CompoAtlas

Eucalyptus citronnée Gingembre Harpagophytum Curcuma Bio

Food supplement declared in France, declaration No 2021-1-1123

Eucalyptus citronnée Gingembre Harpagophytum Curcuma Bio (Yves Ponroy) is a food supplement declared in France. Status: withdrawn from the market on 31 July 2026. Main ingredients: Curcuma longa 133 mg per day, Bambusa bambos 106 mg per day, Boswellia serrata 80 mg per day, Harpagophytum procumbens 80 mg per day, Malpighia glabra 56 mg per day. 1 rule of use applies to its ingredients (limits and warnings).

Brand
Yves Ponroy
Food business operator placing the product on the market
HAVEA COMMERCIAL SERVICES
Status
Withdrawn from the market on 31 July 2026
Form
Capsule
Daily dose
2 gélules
Directions for use
à avaler avec un grand verre d'eau
Intended populations
Men, Women
Not recommended (according to the manufacturer)
Adolescents (under 18), Breastfeeding women, Children (under 12), Young children (aged 1 to 3), Pregnant women, Infants (under 1 year), Taking anticoagulants, Ulcer (stomach or duodenum), Prolonged use

Declaration 221768, procedure Article 16. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Curcuma longa L.RhizomeExtrait sec alcoolique133 mg
Bambusa bambos (L.) VossExsudatExtrait sec aqueux106 mg
Boswellia serrata Roxb. ex Colebr.Gomme résineExtrait sec aqueux80 mg
Harpagophytum procumbensRacineExtrait sec aqueux80 mg
Malpighia glabra L.FruitExtrait sec aqueux56 mg
Corymbia citriodora (Hook.) K.D.Hill & L.A.S. JohnsonEssence (feuille)Distillation20 mg
Zingiber officinale RoscoeEssence (rhizome)Distillation20 mg
Ocimum basilicum L.FeuilleAutre extrait sec16.8 mg
Lentinula edodes(Berk.) PeglerPlante entièreAutre extrait sec11.2 mg
Piper nigrum L.GrainePoudre (de plantes séchées ou broyées)10 mg

Other active ingredients

NamePer day
Fibres solubles d'acacianot declared

Additives

E504, E553b

Other ingredients

Gélule végétale

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Label warnings

Réservé à l’adulte. Consulter votre médecin ou votre pharmacien en cas d’usage concomitant d’anticoagulants. Ne pas utiliser en cas d’ulcère gastrique ou duodénal ou de calculs biliaires. Pas d’utilisation prolongée sans avis d’un spécialiste. Ne pas dépasser la dose recommandée. Ne pas utiliser chez les femmes enceintes ou allaitantes. Consultez un professionnel de santé. À conserver dans un endroit sec et frais à l’abri de la chaleur et de la lumière. À consommer dans le cadre d’une alimentation variée et équilibrée et d’un mode de vie sain. Garder hors de portée des enfants.

Regulatory points

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Curcuma longa L.
    Read the warning, when it applies and the studies cited

    TURMERIC - CURCUMA LONGA - Oral

    Route of administration: Oral (ESCOP 2003; Blumenthal et al. 2000)

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (ESCOP 2003; Brinker 2001; McGuffin et al. 1997).

    Sources cited by Health Canada (2)
    • ESCOP: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
    • McGuffin M, Hobbs C, Upton R, Goldberg A, editors. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL): CRC Press; 1997.

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a liver or biliary disorder (HC 2025; EMA 2018; Brinker 2010; ESCOP 2003; McGuffin et al. 1997).

    Sources cited by Health Canada (6)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • EMA 2018. European Medicines Agency. European Union herbal monograph on Curcuma longa L., rhizome. London (GB): EMA Committee on Herbal Medicinal Products (HMPC); 25 September 2018. [Accessed 2023 October 14] Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-curcuma-longa-l-rhizoma-revision-1_en.pdf
    • ESCOP: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
    • HC 2025: Health Canada: Summary Safety Review - Turmeric and Curcuminoids for Oral Use - Assessing the Potential Risk of Hepatotoxicity. Available from: https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR1758121117867
    • McGuffin M, Hobbs C, Upton R, Goldberg A, editors. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL): CRC Press; 1997.
    • SC 2025: Santé Canada : Résumé de l'examen de l'innocuité - Curcuma et curcuminoïdes pour usage oral - Évaluation du risque potentiel d'hépatotoxicité. Disponible à : https://pmps.hpfb-dgpsa.ca/documents-d-examen/ressource/SSR1758121117867

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking medications (HC 2025).

    Sources cited by Health Canada (2)
    • HC 2025: Health Canada: Summary Safety Review - Turmeric and Curcuminoids for Oral Use - Assessing the Potential Risk of Hepatotoxicity. Available from: https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR1758121117867
    • SC 2025: Santé Canada : Résumé de l'examen de l'innocuité - Curcuma et curcuminoïdes pour usage oral - Évaluation du risque potentiel d'hépatotoxicité. Disponible à : https://pmps.hpfb-dgpsa.ca/documents-d-examen/ressource/SSR1758121117867

    Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if you experience any new symptoms including yellowing of the eyes or skin, dark urine, nausea, vomiting, stomach pain (HC 2025).

    Sources cited by Health Canada (2)
    • HC 2025: Health Canada: Summary Safety Review - Turmeric and Curcuminoids for Oral Use - Assessing the Potential Risk of Hepatotoxicity. Available from: https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR1758121117867
    • SC 2025: Santé Canada : Résumé de l'examen de l'innocuité - Curcuma et curcuminoïdes pour usage oral - Évaluation du risque potentiel d'hépatotoxicité. Disponible à : https://pmps.hpfb-dgpsa.ca/documents-d-examen/ressource/SSR1758121117867

    Condition of application: All uses except for Source of antioxidants and Hepatoprotectant.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 26 September 2025

    Turmeric -CURCUMA LONGA - Topical

    Cautions and warnings

    For external use only.

    When using this product avoid contact with eyes. If contact occurs, rinse thoroughly with water.

    Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or last (for) more than 7 days.

    Keep out of reach of children. If swallowed, call a poison control centre or get medical help right away.

    Contraindications

    Do not use on deep or puncture wounds, animal bites or serious burns.

    Health Canada monograph dated 28 February 2025

  • Harpagophytum procumbens
    Read the warning, when it applies and the studies cited

    DEVIL'S CLAW - HARPAGOPHYTUM

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Health Canada monograph dated 27 March 2026

  • Zingiber officinale Roscoe
    Read the warning, when it applies and the studies cited

    GINGER - ZINGIBER OFFICINALE

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 19 December 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Brand : Yves Ponroy

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Eucalyptus citronnée Gingembre Harpagophytum Curcuma Bio (Yves Ponroy): composition and regulation”, https://compoatlas.com/en/supplements/products/221768-eucalyptus-citronnee-gingembre-harpagophytum-curcuma-bio, updated 15 November 2026.

Enter to analyse, Shift+Enter for a new line